Subscribe to Updates in Legal, Economic & Regulatory Affairs

RSS By Email

RSS By RSS

Add to Google Reader or Homepage

Subscribe in Bloglines


The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.


This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

Study Group: Political Experts (outside Washington DC)(?)

Council Members in this Study Group: 700

This study group may include professors, attorneys, former regulatory officers, and consultants knowledgeable on topics such as law and litigation issues, lobbying, policy and government, elections, antitrust, immigration, intellectual property, and legislation, among others.

Request a survey with this Study Group







Leading Experts in this Study Group

What is a GLG Leader?
Paul Equale, Principal, EQUALE AND ASSOCIATESPaul Equale
Principal
EQUALE AND ASSOCIATES

Paul Equale is the President of Equale & Associates, where he consults on financial services issues, including credit cards, subprime mortgages, GSEs Fannie Mae/Freddie Mac, online gaming, state, federal legislative and regulatory insurance issues, as well as domestic and international political and...


2 recent news post(s)
1 recent event(s)
Jeff Stier, Associate Director, American Council on Science and HealthJeff Stier
Associate Director
American Council on Science and Health

Jeff Stier is an Associate Director at the American Council on Science and Health, a public health and consumer advocacy organization dedicated to promoting sound science in public health. In this position, he is responsible for government relations, policy, legal affairs and development. Mr. Stier...


28 recent news post(s)
Deborah Outlaw, JD
Principal
THE OUTLAW GROUP

Deborah Outlaw is the Principal of The Outlaw Group in Washington, DC, where she provides legislative, regulatory and medical coding services to physician specialty groups, allied health providers, medical device manufacturers, and non-profit organizations interested in medical research. With over 25...


2 recent event(s)

Related Study Groups

GLG NewsSMAnalyses by this Study Group's Experts(?)

Opinions and analyses expressed in GLG News are solely those of the author. See the Terms of Use for details.
Will The New Push To Limit DTC Advertising Advance? | 05-08-2008
Analysis of: New Rules on Drug Ads Sought | online.wsj.com
Author: Jeff Stier, Associate Director, American Council on Science and Health

Billions of dollars in pharmaceutical revenue, a large chunk of the advertising industry, and public health implications are at stake as Congress once again considers stricter limits on direct to consumer (DTC) advertising.

Generic Biologics Won't Get A Free Ride | 04-30-2008
Analysis of: Don't compromise the safety of biotech drugs | www.latimes.com
Author: Jeff Stier, Associate Director, American Council on Science and Health

Allowing "generic" versions of biotech drugs to market without full safety testing would endanger consumers

Good News on the Horizon for Pharmaceuticals | 02-25-2008
Analysis of: Justices Shield Medical Devices From Lawsuits | www.nytimes.com
Author: Jeff Stier, Associate Director, American Council on Science and Health

The decision on medical devices is good news for pharmaceuticals. If medicines get the same protection -- it could bode well -- for reasons beyond the obvious.

Regulatory Change Could Mean Millions to Big Pharma | 02-19-2008
Analysis of: F.D.A. Seeks to Broaden Range of Use for Drugs | www.nytimes.com
Author: Jeff Stier, Associate Director, American Council on Science and Health

A proposed regulatory change proposed on the Friday before a holiday weekend could have a major impact on pharmaceutical profits (and consumer health).

Consumer Product Safety Legislation Creates New Perils for Imports | 02-11-2008
Analysis of: Senate nears vote on product safety overhaul | www.reuters.com
Author: Jeff Stier, Associate Director, American Council on Science and Health

This bill can significantly impact commerce.  Product liability and the ability to import products from developing countries may be acutely affected. Analysis includes not only who the bill hurts, but who it may help.

View All GLG News by members of this Study Group

GLG InstituteSM Seminars with this Study Group's Leaders(?)

 

Recent Seminars

GLGi: CMS Reimbursements: Medical Devices
Boston, 09-20-2006
GLGi: CMS Reimbursements: Medical Devices
New York, 09-19-2006
GLGi: Terrorism Risk Insurance Act
New York, 12-06-2005

Most Common Company Types:

  • Academic Institution*
  • Lobbying Firm
  • Policy or Political Consulting Firm
  • Advocacy Group or Issue Focused
  • Law Firm (general practice/large)
  • Think Tank
  • Professional or Industry Association*

Most Common Job Types:

  • Professor
  • Assistant Professor
  • Director
  • Lobbyist
  • Partner
  • Principal
  • President

GLG's 750+ Clients Include:

40 of the leading 50
global mutual funds
15 of the leading 20
global banks
8 of the leading 10
private equity firms
90%+ client subscription renewal rate

Analytics